Jon Coleman
CIK: 0001442689
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (40.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DXCM
DEXCOM INC
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 4, 2026DXCM
DEXCOM INC
Sale(S)Direct4.9K shares at avg. $74.13$364K - Jun 3, 2026DXCM
DEXCOM INC
Sale(S)Direct4.9K shares at avg. $73.00$359K - May 22, 2026DXCM
DEXCOM INC
Tax Payment(F)Direct7.4K shares at avg. $71.90$529K - Mar 8, 2026DXCM
DEXCOM INC
Award(A)Direct43.9K shares- - May 22, 2025DXCM
DEXCOM INC
Award(A)Direct68.7K shares-
1-5 of 5 transactions
About Coleman Jon
Coleman Jon (SEC CIK 0001442689) files insider reports with the SEC as EVP, Chief Commercial Officer of DEXCOM INC (DXCM).
Signal8 holds 5 ownership filings by Coleman Jon (1 Form 3, 4 Form 4), filed between Mar 31, 2025 and Jun 5, 2026. Those filings report 5 transactions, from May 22, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Coleman Jon's filings is in SAN DIEGO, CA.
Recent filings by Coleman Jon
- Jun 4, 2026: Open-market sale of DXCM shares (Form 4, code S).
- Jun 3, 2026: Open-market sale of DXCM shares (Form 4, code S).
- May 22, 2026: Tax withholding of DXCM shares (Form 4, code F).
- Mar 8, 2026: Grant or award of DXCM shares (Form 4, code A).
- May 22, 2025: Grant or award of DXCM shares (Form 4, code A).
Other insiders filing for DEXCOM INC (DXCM)
- Ashley Euan A., Director
- Stern Sadie, EVP Chief People & Culture Off
- Brown Michael Jon, EVP Chief Legal Compliance Off
- AUGUSTINOS NICHOLAS, Director
- Sylvain Jereme M, EVP, Chief Financal Officer
- Boehnlein Glenn S, Director